Learn about the safety and tolerability of CK-3828136 after a single dose and multiple doses in healthy subjects. Find out how much CK-3828136 is in the blood after a single dose and multiple doses. Determine the effect different doses of CK-3828136 on the pumping function of the heart.
1 Primary · 3 Secondary · Reporting Duration: Time Frame for Food Effect Cohort: Days 1 to 7 (Treatment Periods 1 and 2)
78 Total Participants · 5 Treatment Groups
Primary Treatment: CK-3828136 for SAD Cohort · Has Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Age 18 - 45 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|Labcorp Clinical Research Unit Inc.||100.0%|